Diphtheria Vaccine Immunity in Patients with Type 1 Diabetes Mellitus
PDF
Cite
Share
Request
Original Investigation
VOLUME: 15 ISSUE: 1
P: 21 - 23
March 2014

Diphtheria Vaccine Immunity in Patients with Type 1 Diabetes Mellitus

İstanbul Med J 2014;15(1):21-23
1. Department of Pediatrics Faculty of Medicine, Gazi University, Ankara, Türkiye
2. Department of Pediatric Endocrinology Faculty of Medicine, Gazi University, Ankara, Türkiye
3. Department of Immunology Faculty of Medicine, Gazi University, Ankara, Türkiye
No information available.
No information available
Received Date: 22.12.2012
Accepted Date: 27.05.2013
PDF
Cite
Share
Request

ABSTRACT

Conclusion:

Our results indicate that the impairment of the immune response in Type 1 DM patients could be antigen specific and not a general event, and require further investigation in a larger study.

Results:

Overall, 23% (9/40) of the patients and 25% (11/40) of healthy controls had insufficient immunity against diphtheria. There was no statistical significant difference for diphtheria antibody levels between patients and controls (X2=0.267, p=0.797).

Methods:

Diphtheria antitoxin levels were measured in serum samples of 40 patients and 40 age and sex matched healthy subjects.

Objective:

Patients with Type 1 diabetes mellitus (DM) may have abnormalities in immune function and presumed increased morbidity and mortality from infections. The aim of this study was to compare the diphtheria antitoxin levels in immunized children with Type 1 DM and healthy children.

Keywords:
Type 1 diabetes mellitus, diphtheria antitoxin, vaccine